Prediction of asymptomatic cirrhosis in chronic hepatitis C patients: Accuracy of artificial neural networks compared with logistic regression models

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 6, 2009, Pages 681-687

  Cazzaniga, Massimo ^a,f   Salerno, Francesco ^a   Borroni, Gianmario ^b   Ceriani, Roberto ^c   Stucchi, Giulia ^a   Guerzoni, Patrizia ^d   Casiraghi, Maria Antonietta ^e   Tommasini, Maurizio ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b Alcohol Unit   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d OSPEDALE DI CIRCOLO   (Italy)

^e Legnano Hospital   (Italy)

^f IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

Artificial neural networks; Aspartate aminotransferase to platelet ratio index; Cirrhosis; Hepatitis C; Prediction

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ARTIFICIAL NEURAL NETWORK; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EXTERNAL VALIDITY; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTERNAL VALIDITY; INTERNATIONAL NORMALIZED RATIO; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER HISTOLOGY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; REPRODUCIBILITY; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; STANDARD; THROMBOCYTE;

ADULT; AGE FACTORS; ASPARTATE AMINOTRANSFERASES; BIOPSY, NEEDLE; EPIDEMIOLOGIC METHODS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); PLATELET COUNT; SEX FACTORS;

EID: 67649635437     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328317f4da     Document Type: Article

References (38)

1. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 2000; 132:296-305.
2. Hepatitis C global prevalence (update). Weekly Epidemiol Rec 2000; 75:18-19.
3. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consensus Statements 2002; 19:1-46.
4. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349:825-832.
5. Perrillo RP. The role of liver biopsy in hepatitis C. Hepatology 1997; 26:57S-61S.
6. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32: 477-481.
7. Perrault J, McGill DB, Ott BJ, Taylor WF. Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology 1978; 74:103-106.
8. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy: a multicentre retrospective study on 68276 biopsies. J Hepatol 1986; 2:165-173.
9. Janes CH, Lindor KD. Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med 1993; 118:96-98.
10. Van Leeuwen DJ, Wilson L, Crowe DR. Liver biopsy in the mid-1990s: questions and answers. Semin Liver Dis 1995; 15:340-359.
11. Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis: relationship to cirrhosis. Gastroenterology 1988; 95:734-739.
12. Bonacini M, Hadi G, Govindarajan S, Lindsay KL Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1997; 92:1302-1304.
13. Giannini E, Risso D, Botta F, Romagnoli P, Malfatti F, Fumagalli A, ef a/. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 2003; 163:218-224.
14. Wai CT, Greenson JK, Fontana PJ, Kaibfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple non-invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38:518-526.
15. Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol 2001; 96:3142-3146.
16. Poynard T, Bedossa P, METAVIR and CLINIVIR cooperative study groups. Age and platelet count: a simple index for predicting the presence of
17. histological lesions in patients with antibodies to hepatitis C virus. J Viral Hepat 1997; 4:199-208.
18. Lok ASF, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, ef a/. Predicting cirrhosis in patients with hepatitis C based on Standard Laboratory Tests: results of the HALT-C cohort. Hepatology 2005; 42: 282-292.
19. Lackner C, Struber G, Liegl B, Leibi S, Ofner P, Bankuti C, et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 2005; 41:1376-1382.
20. Shaheen AAM, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitits C-related fibrosis: a systematic review. Hepatology 2007; 46:912-921.
21. Bourliere M, Penaranda G, Renou C, Botta-Fridlund D, Tran A, Portal I, et al. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies. J Viral Hepat 2006; 13: 659-670.
22. Borroni G, Ceriani R, Cazzaniga M, Tommasini M, Roncalli M, Maltempo C, et al. Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C. Aliment Pharmacol Ther 2006; 24:797-804.
23. Cross SS, Harrison RF, Kennedy RL Introduction to neural networks. Lancet 1995; 346:1075-1079.
24. Baxt WG. Application of artificial neural networks to clinical medicine. Lancet 1995; 346:1135-1138.
25. Forsstrom JJ, Dalton KJ. Artificial neural networks for decision support in clinical medicine. Ann Wed 1995; 27:509-517.
26. Dayhoff J, Deleo J. Artificial neural networks: opening the black box. Cancer 2001; 91:1615-1635.
27. Baxt W, Skora J. Prospective validation of an artificial neural network trained to identify acute myocardial infarction. Lancet 1996; 347:12-15.
28. Baxt W, Shofer F, Sites F, Hollander JE. A neural network aid for the early diagnosis of cardiac ischaemia in patients presenting to the emergency department with chest pain. Ann Emerg Med 2002; 40:575-583.
29. Haydon GH, Jalan R, Ala-Korpela M, Hiltunen Y, Hanley J, Jarvis LM, et al. Prediction of cirrhosis in patients with chronic hepatitis C infection by artificial neural network analysis of virus and clinical factors. J Viral Hepat 1998; 5:255-264.
30. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histologic activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:431-435.
31. Rumelhart D, Hinton G, Williams R. Learning representation by backpropagating errors. Nature 1986; 323:533-536.
32. Hanley JA, McNeil BJ. The meaning and the use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36.
33. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148:839-843.
34. Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet 2005; 365:1500-1505.
35. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470.
36. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357:1069-1075.
37. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48:835-847.
38. Sebastiani G, Vario A, Guido M, Noventa F, Plebani M, Pistis R, et al. Stepwise combination algorithms of noninvasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 2006; 44:686-693.